Botanix Pharmaceuticals Limited

OTCPK:BXPH.F Stock Report

Market Cap: US$169.8m

Botanix Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BXPH.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Nov 25BuyUS$2,032,098Copia Investment Partners LtdCompany20,600,000US$0.11
10 Nov 25SellUS$1,268,886MLC Investments LimitedCompany14,959,748US$0.085
07 Nov 25SellUS$1,013,692IOOF Investment Management LimitedCompany5,779,544US$0.18
03 Nov 25BuyUS$8,817IOOF Investment Management LimitedCompany100,000US$0.088
28 Oct 25SellUS$1,732,107IOOF Investment Management LimitedCompany10,977,635US$0.18
23 Oct 25BuyUS$1,226,771MLC Investments LimitedCompany6,347,313US$0.19
20 Oct 25BuyUS$538,377IOOF Investment Management LimitedCompany3,685,867US$0.20
26 Sep 25BuyUS$2,326,916Copia Investment Partners LtdCompany20,000,000US$0.21
23 Sep 25SellUS$1,470,541MLC Investments LimitedCompany14,313,367US$0.10
26 Jun 25BuyUS$7,019,542Copia Investment Partners LtdCompany29,824,352US$0.29
20 Jun 25BuyUS$85,431OnePath Funds Management LimitedCompany440,527US$0.19
24 Apr 25BuyUS$4,464,353UniSuper Management Pty LtdCompany36,333,941US$0.27
24 Apr 25BuyUS$986,763IOOF Investment Management LimitedCompany3,339,583US$0.31
19 Apr 25SellUS$762,462IOOF Investment Management LimitedCompany4,469,401US$0.25
14 Apr 25SellUS$4,505,254MLC Investments LimitedCompany15,340,743US$0.29
31 Mar 25SellUS$14,549Copia Investment Partners LtdCompany50,000US$0.31
24 Mar 25BuyUS$712,707MLC Investments LimitedCompany2,616,522US$0.27
21 Mar 25BuyUS$1,618,899OnePath Funds Management LimitedCompany5,735,488US$0.28
21 Feb 25SellUS$257,501UniSuper Management Pty LtdCompany774,352US$0.33

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BXPH.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies22,272,2221.13%
Private Companies38,474,8491.95%
Individual Insiders182,774,4849.28%
Institutions443,838,83222.5%
General Public1,282,742,43365.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 34.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.24%
Copia Investment Partners Ltd
142,700,000US$12.3m16.9%3.4%
4.94%
UniSuper Management Pty Ltd
97,402,778US$8.4m0%0.04%
4.18%
MLC Investments Limited
82,321,881US$7.1m-25.8%1.99%
3.79%
Matthew Callahan
74,586,791US$6.4m0%no data
2.67%
Gayle McGarry
52,573,874US$4.5m0%no data
1.67%
The Vanguard Group, Inc.
32,959,030US$2.8m4.51%no data
1.64%
IOOF Investment Management Limited
32,240,249US$2.8m-84.4%0.13%
1.24%
Antares Capital Partners Limited
24,386,669US$2.1m0%11.76%
1.13%
Zenith Energy Ltd.
22,272,222US$1.9m0%no data
0.96%
Henry Bosch
18,836,702US$1.6m0%no data
0.77%
Yarraandoo Pty Ltd
15,166,667US$1.3m0%no data
0.76%
Vincent Ippolito
15,001,644US$1.3m0%no data
0.63%
Matthew Moffatt Family Trust
12,378,182US$1.1m0%no data
0.55%
Rollo Corp Property Holdings Pty Ltd
10,930,000US$942.0k0%no data
0.42%
Netwealth Investments Ltd.
8,277,790US$713.4k0%0.01%
0.4%
Nicolas Fayd'herbe
7,888,032US$679.8k0%no data
0.31%
OnePath Funds Management Limited
6,176,015US$532.3k7.68%2.74%
0.28%
Allianz Asset Management GmbH
5,528,397US$476.4k0%no data
0.27%
Australian Super Pty Ltd
5,259,879US$453.3k0%no data
0.27%
Daniel Sharp
5,242,458US$451.8k0%no data
0.24%
Stewart Washer
4,644,983US$400.3k0%no data
0.2%
Howie McKibbon
4,000,000US$344.7k0%no data
0.093%
Fideuram Asset Management (Ireland) DAC
1,830,004US$157.7k0%no data
0.088%
Allianz Global Investors U.S. LLC
1,729,374US$149.0k0%no data
0.061%
BlackRock, Inc.
1,207,829US$104.1k43%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/25 05:26
End of Day Share Price 2026/01/20 00:00
Earnings2025/06/30
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Botanix Pharmaceuticals Limited is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madeleine WilliamsCanaccord Genuity
Joseph PantginisH.C. Wainwright & Co.